Quote For Onyx Pharmaceuticals Inc ONXX.O
Onyx Pharmaceuticals Inc (ONXX.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare ·
industry: Biotechnology ·
$28.63
25 Nov 2009
+0.00%
$28.63
--
414,617
$28.63
$28.63
$37.02
$21.85
0.64
772,093
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Coles, N. Anthony | President, Chief Executive Officer, Director | 2,770,810 |
| Fust, Matthew | Chief Financial Officer, Executive Vice President, Principal Accounting Officer | -- |
| Brege, Laura | Chief Operating Officer, Executive Vice President | 1,705,190 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $1,778.93 |
| Shares Outstanding (Mil.) | 62.14 |
| Float (Mil.) | 62.00 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 13.87 |
| Current Ratio | 37.73 |
| LT Debt/Equity | 18.91 |
| Total Debt/Equity | 18.91 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 7.64 |
| Price/Book(TTM) | 2.38 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.16 |
| Sales(TTM) | $4.02 |
| Book Value(MRQ) | $12.05 |
| Cash Flow(TTM) | $-0.12 |
| Cash(MRQ) | $12.95 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -1.37 |
| Return on Assets(TTM) | -1.17 |
| Return on Investment(TTM) | -1.21 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -4.54 |
| Profit Margin(TTM) % | -3.66 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
